Search results
Merck Expands Access to High-Quality Maternal Care for More
3BL CSRwire· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global maternal health initiative ...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 6 days agoThe company's stock felt the pressure from a downturn in COVID-19 product sales last year, and the investment community expressed dissatisfaction with...
UK’s leading lab supplier launches investigation into N-word slurs on products
The Independent via Yahoo News· 7 days ago(Screenshot) Cell culture lines...scientific research to better understand the human body, improve...
Cinven to explore $3 billion sale of software maker Jaggaer, sources say
WHTC 1450 Holland· 2 days agoBy Milana Vinn NEW YORK (Reuters) - Private equity firm Cinven is preparing to explore a sale of Jaggaer that it hopes will value the maker of supply chain software at about $3 billion, including ...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 2 days agoGlobalData, the parent company of Pharmaceutical Technology...Simultaneously, international pharma companies have conducted clinical research on Brazil’s...
...ETFs Post Q1 Earnings - Bristol-Myers Squibb (NYSE:BMY), First Trust Nasdaq Pharmaceuticals ETF...
Benzinga· 6 days agoThe first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of...
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks via Yahoo Finance· 7 days agoLast month, VKTX completed the 52-week biopsies in the VOYAGE study. Viking intends to report...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 5 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
mAbxience Appoints Jurgen Van Broeck as New CEO
WRBL Columbus· 6 days agoJurgen, who has served as Global Commercial Director since June 2023, brings a great deal of experience and a proven track record in the pharmaceutical and biosimilars industries ...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024...
